The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.
The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
The Chase Group Secures the Vice President, Global Head of Data Sciences, for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.
The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
-
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on… -
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,… -
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… -
The Chase Group Secures Teng Jin Ong for Genmab
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… -
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… -
Leadership Team Grows at Biologics Consulting Through Partnership With The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…